Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

PEDIATRIC ASSOCIATES

NPI: 1205974623 · EAST PROVIDENCE, RI 02914 · Pediatrics Physician · NPI assigned 02/01/2007

$1.30M
Total Medicaid Paid
27,498
Total Claims
25,858
Beneficiaries
25
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialTOWNSEND, KIMBERLEY (PRESIDENT)
NPI Enumeration Date02/01/2007

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 2,916 $112K
2019 3,037 $114K
2020 1,884 $60K
2021 2,285 $73K
2022 4,464 $221K
2023 6,926 $388K
2024 5,986 $333K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 11,031 10,232 $789K
90460 Immunization administration through 18 years of age via any route, first or only component 7,508 7,160 $140K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 1,152 1,137 $116K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 758 701 $71K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 571 555 $57K
90461 1,543 1,481 $52K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 276 262 $30K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 281 272 $7K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 639 589 $6K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 710 684 $5K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 184 181 $5K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 43 40 $5K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 309 181 $4K
96127 931 894 $3K
90480 74 73 $3K
96110 Developmental screening, with scoring and documentation, per standardized instrument 200 194 $3K
87081 581 543 $3K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 26 26 $1K
99177 229 211 $1K
96161 171 165 $650.48
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 26 24 $577.50
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 13 13 $487.24
99173 116 115 $238.70
90686 93 92 $45.00
90656 33 33 $16.00